|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61N 1/30 | |
| A61K 9/70 | |||
| A61M 37/00 |
| (11) | Number of the document | 2421601 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10767443.4 |
| Date of filing the European patent application | 2010-04-26 | |
| (97) | Date of publication of the European application | 2012-02-29 |
| (45) | Date of publication and mention of the grant of the patent | 2016-06-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/001227 |
| Date | 2010-04-26 |
| (87) | Number | WO 2010/123584 |
| Date | 2010-10-28 |
| (30) | Number | Date | Country code |
| 214642 P | 2009-04-25 | US | |
| 217011 P | 2009-05-23 | US | |
| 459862 | 2009-07-07 | US |
| (72) |
IMRAN, Mir, US
HASHIM, Mir, US
PATEL, Sanjay, US
BERENSON, Ronald, J., US
|
| (73) |
Incube Labs, LLC,
2051 Ringwood Avenue, San Jose, CA 95131,
US
|
| (54) | SYSTEM FOR TRANSDERMAL IONTOPHORETIC DELIVERY OF CHELATED AGENTS |
| SYSTEM FOR TRANSDERMAL IONTOPHORETIC DELIVERY OF CHELATED AGENTS |